CD44 antigens, which are themselves glycoproteins, function as receptors of proteoglycans (one subtype of glycan) including hyaluronic acid [2,60,69,70] and chondroitin sulfates [71,72], and these interactions are known to be tumor-associated [2]. Here, CD44 is linked to neoplasm.